September 15, 2025: CVS Caremark Under Fire for Dropping Zepbound from Its List of Covered Medications Stakeholders have sued CVS Caremark, a Pharmacy Benefit Manager, for taking Zepbound off its list of preferred formularies
This advancement offers patients a convenient, needle-free option that doesn't require refrigeration, potentially making effective weight management accessible to more people who may have been hesitant about injections or faced barriers to using injectable medications
Supplementing with the glutathione precursors for 24 weeks successfully reversed these metabolic defects, corrected the glucose steal, and led to significant, measurable improvements in cognition and executive function
This delayed response explains why hair loss often begins months after starting a GLP-1 medication
It is unknown exactly who will be able to receive a retatrutide prescription this will only be determined when the FDA approves the drug